Adage Capital Management, L.P. - 31 Dec 2025 SCHEDULE 13G Report for Relmada Therapeutics, Inc. Common Stock, par value $0.001 per share (RLMD)

Filing Manager
Adage Capital Management, L.P.
Reporting Manager
Adage Capital Management, L.P.
Security
Relmada Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
RLMD
Shares outstanding
73,367,698 shares
Disclosed Ownership
4,270,000 shares
Ownership
5.8%
Form type
SCHEDULE 13G
Filing time
12 Feb 2026, 09:13:06 UTC
Date of event
31 Dec 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Adage Capital Management, L.P. disclosed 5.8% ownership in Relmada Therapeutics, Inc. Common Stock, par value $0.001 per share (RLMD) on 31 Dec 2025."

Quick Takeaways

  • Adage Capital Management, L.P. filed SCHEDULE 13G for Relmada Therapeutics, Inc. Common Stock, par value $0.001 per share (RLMD).
  • Disclosed ownership: 5.8%.
  • Date of event: 31 Dec 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 12 Feb 2026, 09:13.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Adage Capital Management, L.P. 5.8% 4,270,000 0 4,270,000 /s/ Robert Atchinson By: Adage Capital Partners LLC, its General Partner, By: Robert Atchinson, its Managing Member
Robert Atchinson 5.8% 4,270,000 0 4,270,000 /s/ Robert Atchinson Robert Atchinson, individually
Phillip Gross 5.8% 4,270,000 0 4,270,000 /s/ Phillip Gross Phillip Gross, individually

Sponsored